NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Stratus Therapeutics

Stratus Therapeutics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://stratustx.com/

Last Round

Series A

Extension

Mar 12, 2025

Total Funding Raised

$184M

Company Overview

Stratus Therapeutics is a biotechnology company developing on-demand, off-the-shelf hematopoietic stem cell therapies for blood and immune system disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

hematopoietic stem cellHSCcell therapyallogeneic cell therapyoff-the-shelf therapyimmune reconstitutiongraft-versus-host diseaseGvHDbiotechnologystem cell transplantationregenerative medicinehematopoietic progenitor cellHPCclinical-stage biotechdonor-free transplant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stratus Therapeutics Comparables

Compare Stratus Therapeutics with similar companies based on industry and business-model similarity.

Stratus Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Garuda Therapeutics
100%
Cell BioEngines, Inc.
83%
Gamida Cell Ltd.
72%

Stratus Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 12, 2025
Series BFeb 7, 2023
Series ASep 23, 2021

Stratus Therapeutics Investors

Notable investors and investment history

Stratus Therapeutics investors
InvestorRounds
Ridgeback CapitalSeries A
Cormorant Asset ManagementSeries A, Series A Extension, Series B
Mass General Brigham InnovationSeries B, Series A
OrbiMedSeries A Extension, Series B, Series A
Northpond VenturesSeries A Extension, Series B, Series A
Alexandria Venture InvestmentsSeries B
Aisling CapitalSeries B, Series A

Stratus Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Stratus Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Stratus Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range17
Year Founded2021
Last FundingMar 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.